News

バイオ技術パイプラインの最新情報 — 2014年

Nature Biotechnology 33, 2 doi: 10.1038/nbt.3136

Approvals of new chemical and biologic entities surged again in 2014, shepherded along by a confident FDA, as industry reaped the rewards of drug development incentives. Chris Morrison reports.

目次へ戻る

プライバシーマーク制度